Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 978 results for "for merck"

Pfizer Inc. (PFE) Strikes $2.85 Billion Deal With Merck KGaA To Co-Develop Cancer Immunotherapy Drug
Bidness Etc

Pfizer/Merck KGaA Immune Checkpoint Deal Bodes Extremely Well ...

Summary Pfizer licenses Merck KGaA's early (clinical) stage cancer immunotherapy in record licensing agreement: $850 million upfront, $2 billion milestones, 50% royalty. This deal represents the best pure-play comparable for the cancer ... Seeking Alpha, 23 hours ago

256 images for for merck

One News Page United Kingdom, 1 day ago
Xconomy, 1 day ago
BusinessWeek, 5 days ago
Irish Times, 5 days ago
Fidelity Brokerage Services LLC, 5 days ago
CTV News, 4 days ago
Jutia Group, 4 days ago
Pharma Letter, 4 days ago, 5 days ago, 4 days ago
Bidness Etc

NewLink Genetics, Merck and Co. (MRK) In Talks To Scale Up Ebola Vaccine Production

Biotech NewLink and pharma giant Merck have reportedly come together to find ways to accelerate production of NewLink's experimental Ebola vaccine Page 1 of 2 Click Ticker to See live coverage NewLink Genetics Corp ( NASDAQ:NLNK ) and ...
 Bidness Etc1 day ago NewLink Said in Talks With Merck & Co. to Produce Ebola Vaccine  Washington Post1 day ago NewLink in Talks With Merck on Producing Ebola Vaccine  BusinessWeek1 day ago Merck in talks with NewLink to scale up Ebola vaccine production: Bloomberg  FiercePharma23 hours ago
Bidness Etc

IMPROVE-IT Gives Another Merck Drug Promise

Earlier this week, Merck announced that Vytorin, a combination pill made up of Zetia and a statin, Zocor, reduced heart attacks and strokes more than Zocor alone in high-risk heart disease patients. These results came from the IMPROVE-IT clinical ...
 Forbes.com18 hours ago Merck and Co.s (MRK) Cholesterol Drug Vytorin Reduced Risk Of Heart Attacks, Study Shows  Bidness Etc4 days ago Merck Drug Works: Vytorin Study Proves Successful  Investor's Business Daily4 days ago Merck & Co's LDL-lowering drug Vytorin meets study endpoints  Pharma Letter4 days ago

Merck Collaboration Rules Out AstraZeneca Acquisition--For Now

Summary Pfizer's multi-billion dollar agreement with Merck excludes either drugmaker from collaborating with other companies on the drug. This class of drugs happens to be one of AstraZeneca's main focuses. The collaboration is a risk for Pfizer, ...
 Seeking Alpha20 hours ago Cramer: Pfizer Deal With Merck Leaves AstraZeneca In the Cold  TheStreet.com5 days ago Pfizer ends Astra bid hopes with Merck deal  Irish Examiner4 days ago Pfizer signs deal with Merck  The Gulf Today4 days ago

Potential Merck (MRK) Trade Targets 2.35% Return

After ThursdayaEUR(TM)s trading in Merck & Co Inc. ("MRK)'s option trade-picking algorithms uncovered a trade that offers a 2.35% or 5.83% (for comparison purposes only), ...
 Individual.com20 hours ago Merck (MRK) Trading Near $58.90 Support Level  Individual.com1 day ago Potential Merck (MRK) Trade Has 5.25% Downside Protection  Individual.com4 days ago

Here's What The Last Few Months Have Been Like For Your Thanksgiving Turkey ...

It's almost turkey time. According to the Merck Veterinary Manual, the process involves "stimulating the copulatory organ by massaging the abdomen and the back over the testes . The semen produced by one male bird - a "tom" - can usually inseminate ...
 Austin American Statesman18 hours ago

You Should Hold Merck According to Dividends Generation

In this article, let's take a look at Merck & Co. Inc. (MRK), a $169.28 billion market cap company, which is one of the world's largest drug makers, acquired Schering-Plough in November 2009. Returning value to shareholders The firm is a leader ...
 Yahoo! Finance21 hours ago

Do The IMPROVE-IT Results Offer Promise For Another Merck Heart Drug - Anacetrapib?

Despite the fact that anacetrapib lowers LDL at least as well as Vytorin did in IMPROVE-IT, the FDA would never approve anacetrapib based solely on LDL lowering. This is a new experimental agent and the results of REVEAL are needed before the FDA ...
 Austin American Statesman1 day ago

Merck partners with Pfizer to co-develop and co-commercialize anti-cancer drug

Merck has entered into an agreement with Pfizer Inc. to co-develop and co-commercialize MSB0010718C, an investigational anti-PD-L1 antibody currently in development by Merck, as a potential treatment for multiple tumor types. The asset will be ...
 Individual.com1 day ago Esperion Therapeutics, Inc. Climbs As CEO Lauds Merck & Co.'s Zetia Data  BioSpace2 days ago Esperion Therapeutics, Inc. (ESPR) Climbs As CEO Lauds Merck & Co. (MRK)'s Zetia Data 11/19/2014  ClinicSpace3 days ago Merck, Pfizer ink alliance on anti-PD-L1  Center Watch3 days ago

Merck lends support in fight against Ebola

Donation of € 250,000 made to the German Red Cross Glenmark Pharmaceuticals has won the Civic Award 2013-14 for Social Development by the Bombay Chamber of Commerce and Industry (BCCI). The accolade was presented to Glenmark for its exemplary ...
 Financial Express1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less